Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand

Publisher： Karger

E-ISSN： 1660-3818|43|5|375-379

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.43, Iss.5, 2016-07, pp. : 375-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 304-307

John Wiley & Sons Inc

Access to resources Recommend Favorite

A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 591-594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Indications for Thrombopoietin and Thrombopoietin-Receptor Agonists

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 5, 2013-09 ,pp. : 319-325

Karger

Access to resources Recommend Favorite

Cytomegalovirus‐associated thrombocytopenia treated with thrombopoietin receptor agonist

By  

INTERNAL MEDICINE JOURNAL, Vol. 46, Iss. 9, 2016-09 ,pp. : 1096-1099

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 1, 2011-12 ,pp. : 5-8

Karger

Access to resources Recommend Favorite